WayFinder Ride Phase I Study

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
AbleLink Smart Living Technologies
Study ID
NCT07437651
Status
Completed

Conditions

  • Lyft App
  • Uber App
  • WayFinder Ride Prototype

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • WayFinder Ride Phase I Prototype — DEVICE
    Cognitively accessible ride share prototype app
  • Lyft Rideshare App — DEVICE
    Use of the Lyft Mainstream App for requesting a ride
  • Uber Rideshare App — DEVICE
    Use of the Uber Mainstream App for requesting a ride

Study Details

Phase I will culminate with a pilot study designed to evaluate the usability and accessibility of the WayFinder Ride prototype system to enable people with IDD to request an Uber or Lyft ride. Participants will rate both systems on factors of usability and accessibility. The number and types of errors and assistance needed using the prototype will be tracked to compare use of each of the applications. It is hypothesized that the participants with IDD will have significantly fewer errors and need less help when using the cognitively accessible WayFinder Ride interface than the Uber or Lyft interfaces. Additionally, it is hypothesized that WayFinder Ride will have significantly higher rating scores on usability and accessibility. Sixty-six people with IDD will participate in this Phase I study.

Key Dates

Start date
Feb 1, 2025
Status verified
Feb 2026
Primary completion
Dec 3, 2025
Completion
Dec 9, 2025

Study Design

Enrollment
60 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Cognitively accessible ride request prototype
    Use of WayFinder Ride prototype
  • Experimental: Mainstream Lyft rideshare app
    Use of Lyft app
  • Experimental: Mainstream Uber rideshare app
    Use of Uber app

Primary Outcome Measure

Rideshare request error percentage [ Time Frame: From enrollment to the end of treatment at 2 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
REACH Collective, Temple UniversityPhiladelphiaPennsylvania19122-

Find similar trials in Philadelphia, PA